Cargando…
Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
OBJECTIVE: To investigate net clinical benefit (NCB) of warfarin in individuals with atrial fibrillation (AF) across stroke risk and across primary and secondary care. METHODS: We conducted a linked electronic health record cohort study of 70 206 individuals with initial record of diagnosis of AF in...
Autores principales: | Allan, Victoria, Banerjee, Amitava, Shah, Anoop Dinesh, Patel, Riyaz, Denaxas, Spiros, Casas, Juan-Pablo, Hemingway, Harry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284481/ https://www.ncbi.nlm.nih.gov/pubmed/27580623 http://dx.doi.org/10.1136/heartjnl-2016-309910 |
Ejemplares similares
-
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019) -
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
por: Bahit, M Cecilia, et al.
Publicado: (2017) -
Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
por: Friberg, Leif, et al.
Publicado: (2017) -
Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis
por: Providência, Rui, et al.
Publicado: (2014) -
Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis
por: Gill, Simrat, et al.
Publicado: (2022)